Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea

BACKGROUND: Iron-deficiency anemia (IDA) is prevalent in patients with advanced chronic heart failure (CHF). It affects the patients’ overall physical condition and is suggested as a strong outcome predictor in CHF. Recent clinical trials suggested that intravenous iron supplementation improves CHF...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Eun-A, Sohn, Hyun-Soon, Lee, Haeyoung, Choi, Sang-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166574/
https://www.ncbi.nlm.nih.gov/pubmed/25278814
http://dx.doi.org/10.1186/1478-7547-12-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166574/
https://www.ncbi.nlm.nih.gov/pubmed/25278814
http://dx.doi.org/10.1186/1478-7547-12-19

Ejemplares similares